SEC Form 4 insider trading filings tracked in real time from EDGAR

Smith Jason Drew — General Counsel

Insider trading activity for Smith Jason Drew sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: General Counsel
  • Company: UroGen Pharma Ltd.
  • Total insider trades: 1
  • Total buy volume: $0
  • Total sell volume: $65K
  • Last trade: Sep 8, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Sep 8, 2026 Smith Jason Drew UURGN UroGen Pharma Ltd. SELL 1,519 $65K

← All executives · Full trades feed